Gold Supported By Rising COVID-19 Cases After Vaccine Hit
Although fears over the economic fallout from mounting COVID19 cases supported prices on Friday, gold was headed for its biggest weekly loss since September after positive news about a potential vaccine.
- Last Updated: November 13, 2020, 14:48 IST
- FOLLOW US ON:
Although fears over the economic fallout from mounting COVID-19 cases supported prices on Friday, gold was headed for its biggest weekly loss since September after positive news about a potential vaccine.
Spot gold rose 0.2% to $1,879.20 per ounce by 0814 GMT, but was down 3.7% for the week.
U.S. gold futures gained 0.3% to $1,878.20.
“Investors may also be wary of other companies announcing trial data in the coming weeks, which if successful, could put more downward pressure on gold,” Jeffrey Halley, senior market analyst at OANDA, adding, gold will struggle to reclaim $1,900.
The vaccine optimism has been tempered by spike in cases in the U.S. and Europe.
ED&F Man Capital Markets analyst Edward Meir said people were realising that a significant roll-out of a vaccine will take time, while the need for relief is immediate.
Top Democrats in the U.S. Congress urged renewed talks over a multi-trillion dollar aid proposal, but a top Republican immediately rejected this as too expensive.
“The fact that there isn’t a stimulus coming seems to be keeping a lid on it (gold)… If Congress actually comes up with a limited package, that would be beneficial,” Meir added.
Gold tends to benefit from stimulus measures from central banks as it is considered a hedge against inflation and currency debasement, which has driven a rise of about 24% this year.
Silver rose 0.4% to $24.32. Platinum was up 1% at $888.30, while palladium was 0.5% higher at $2,343.84.
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor